Purchase Order 75N92025P00242
Award Date
6/24/25
Potential Completion Date
9/23/25
Potential Value
$14K
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization. The $10,928.00 award is for the delivery of Oxford Nanopore's DNA sequencing flow cells and reagents to support long-read sequencing activities at the agency's DNA Sequencing Core. The contract has a completion date of November 7, 2023 and does not utilize any...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was made by the National Institute for Minority Health and Health Disparities, a civilian agency. The $16,500.00 firm fixed-price purchase order is for the delivery of OXFORD NANOPORE TECHNOLOGIES, INC.; FLOW CELL R9 4.1 products by December 31, 2023. This contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
This is a $232,150 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian federal agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PROMETHION FLOW CELL PACKS, which are a key consumable component of Oxford Nanopore's PromethION sequencing platform. The contract has a period of performance through May 1, 2028. Oxford Nanopore Technologies Inc. is an established federal...
This is a $161,638 firm-fixed-price purchase order awarded by the Northeast Area division of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of ROSEN - Oxford Nanopore FLO-PRO002 Promethion Flow Cell Packs, which are consumable supplies for Oxford Nanopore's PromethION DNA/RNA sequencing platform. The contract has a completion date of September 14, 2022 and does not have a set-aside designation....
This firm-fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the procurement of 8 packs of 4 PROMETHION flow cells for RNA sequencing. This appears to be part of a larger Indefinite Delivery Vehicle (IDV) that Oxford Nanopore has with the NHGRI, as the company has...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, is for the procurement of 8 packs of 4 PromethION flow cells (RNA) at a ceiling value of $21,835.00. The contract is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The contract does not utilize a set-aside designation and has an ultimate completion date of September 26, 2025....
This federal contract award, valued at $21,835.00, was issued by the National Human Genome Research Institute (NHGRI) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of 8 packs of 4 PROMETHION flow cells, which are consumable components used in Oxford Nanopore's genomic sequencing instruments. The contract does not have a set-aside designation and is a firm fixed-price purchase order, with an ultimate completion date of...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the delivery of reagents to assist investigators working to sequence unresolved regions of the human genome. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has been awarded several...
This is a $21,835.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The purpose of the award is to provide a reagent needed by Shelise Brooks for the preparation of direct RNA libraries for sequencing on the Oxford Nanopore Promethion system in support of the Collins NF_Isletbetacells project led by Dr. Mike Erdos at NHGRI. The contract...
This federal contract award, valued at $30,340.00, was issued by the National Cancer Institute (NCI), a civilian agency within the U.S. government, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the initial supply of flow cells to be used with Oxford Nanopore's P2 instrument for long-read DNA sequencing. The contract has a firm fixed-price structure and an ultimate completion date of September 10, 2025. In addition to this specific...